• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P2X7R 阻断通过抑制 NLRP3 炎性小体激活抑制 Th1/Th17 介导的免疫应答和角膜同种异体移植排斥反应。

Blockage of P2X7R suppresses Th1/Th17-mediated immune responses and corneal allograft rejection via inhibiting NLRP3 inflammasome activation.

机构信息

Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.

Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University, Shanghai, 200031, China; NHC Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences, Shanghai, 200031, China.

出版信息

Exp Eye Res. 2021 Nov;212:108792. doi: 10.1016/j.exer.2021.108792. Epub 2021 Oct 14.

DOI:10.1016/j.exer.2021.108792
PMID:34656546
Abstract

P2X7R is a vital modifier of various inflammatory and immune-related diseases. However, the immunomodulatory effects of P2X7R on corneal allograft rejection remains unknown. Here we showed that P2X7R expression was significantly upregulated in corneal grafts of allogeneic transplant mice. Pharmacological blockage of P2X7R remarkably prolonged graft survival time, and reduced inflammatory cell infiltration in corneal grafts, in particular Th1/Th17 cells. Meanwhile, the frequencies of Th1/Th17 cells in draining lymph nodes were significantly decreased in P2X7R blocked allogeneic mice. Further results showed that the effect of P2X7R on promoting Th1/Th17 mediated immune responses in corneal allograft rejection relied heavily on its activation on the NLRP3/caspase-1/IL-1β axis, while P2X7R blockage could mitigate such activation. Nevertheless, the addition of IL-1β in vivo abrogated the protective effect of P2X7R blockage on promoting corneal graft survival. These findings demonstrate that blockage of P2X7R can substantially alleviate corneal allograft rejection and promote grafts survival, highlighting it as a promising target for preventing or treating corneal allograft rejection.

摘要

P2X7R 是多种炎症和免疫相关疾病的重要调节剂。然而,P2X7R 对角膜同种异体移植物排斥的免疫调节作用尚不清楚。在这里,我们发现 P2X7R 在同种异体移植小鼠的角膜移植物中表达显著上调。P2X7R 的药理学阻断显著延长了移植物的存活时间,并减少了角膜移植物中的炎症细胞浸润,特别是 Th1/Th17 细胞。同时,在 P2X7R 阻断的同种异体小鼠中,引流淋巴结中 Th1/Th17 细胞的频率也显著降低。进一步的结果表明,P2X7R 促进 Th1/Th17 介导的角膜同种异体移植排斥反应的作用在很大程度上依赖于其在 NLRP3/caspase-1/IL-1β 轴上的激活,而 P2X7R 的阻断可以减轻这种激活。然而,体内添加 IL-1β 会消除 P2X7R 阻断对促进角膜移植物存活的保护作用。这些发现表明,阻断 P2X7R 可以显著减轻角膜同种异体移植物排斥反应并促进移植物存活,这突显了它作为预防或治疗角膜同种异体移植物排斥反应的有前途的靶点。

相似文献

1
Blockage of P2X7R suppresses Th1/Th17-mediated immune responses and corneal allograft rejection via inhibiting NLRP3 inflammasome activation.P2X7R 阻断通过抑制 NLRP3 炎性小体激活抑制 Th1/Th17 介导的免疫应答和角膜同种异体移植排斥反应。
Exp Eye Res. 2021 Nov;212:108792. doi: 10.1016/j.exer.2021.108792. Epub 2021 Oct 14.
2
P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes.P2X7R 突变破坏 NLRP3 介导体细胞程序,预测心脏移植物预后不良。
J Clin Invest. 2018 Aug 1;128(8):3490-3503. doi: 10.1172/JCI94524. Epub 2018 Jul 16.
3
Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7.靶向离子型嘌呤能受体 P2X7 延长心脏移植的长期存活率。
Circulation. 2013 Jan 29;127(4):463-75. doi: 10.1161/CIRCULATIONAHA.112.123653. Epub 2012 Dec 18.
4
Resolvin E1 Inhibits Corneal Allograft Rejection in High-Risk Corneal Transplantation.解析 E1 抑制高危角膜移植中的角膜移植排斥反应。
Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):3911-3919. doi: 10.1167/iovs.18-24562.
5
The NLRP3 inflammasome regulates corneal allograft rejection through enhanced phosphorylation of STAT3.NLRP3 炎性小体通过增强 STAT3 的磷酸化调节角膜同种异体移植排斥反应。
Am J Transplant. 2020 Dec;20(12):3354-3366. doi: 10.1111/ajt.16071. Epub 2020 Jun 24.
6
Nlrp3 Inflammasome Inhibitor MCC950 Ameliorates Obliterative Bronchiolitis by Inhibiting Th1/Th17 Response and Promoting Treg Response After Orthotopic Tracheal Transplantation in Mice.NLRP3 炎性体抑制剂 MCC950 通过抑制小鼠原位气管移植后 Th1/Th17 反应和促进 Treg 反应来改善闭塞性细支气管炎。
Transplantation. 2020 Jun;104(6):e151-e163. doi: 10.1097/TP.0000000000003208.
7
Extracellular ATP Activates the NLRP3 Inflammasome and Is an Early Danger Signal of Skin Allograft Rejection.细胞外 ATP 激活 NLRP3 炎性小体,是皮肤同种异体移植排斥的早期危险信号。
Cell Rep. 2017 Dec 19;21(12):3414-3426. doi: 10.1016/j.celrep.2017.11.079.
8
P2X7 receptor antagonists modulate experimental autoimmune neuritis via regulation of NLRP3 inflammasome activation and Th17 and Th1 cell differentiation.P2X7 受体拮抗剂通过调节 NLRP3 炎性体激活和 Th17 和 Th1 细胞分化来调节实验性自身免疫性神经炎。
J Neuroinflammation. 2024 Mar 25;21(1):73. doi: 10.1186/s12974-024-03057-z.
9
Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection.嘌呤能抑制剂氧化型 ATP 在胰岛移植排斥模型中的作用。
Diabetes. 2013 May;62(5):1665-75. doi: 10.2337/db12-0242. Epub 2013 Jan 11.
10
Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection.敲除 microRNA-155 可改善慢性排斥反应中的 Th1/Th17 免疫应答和组织损伤。
J Heart Lung Transplant. 2017 Feb;36(2):175-184. doi: 10.1016/j.healun.2016.04.018. Epub 2016 May 6.

引用本文的文献

1
TLR3-overexpressing umbilical cord mesenchymal stromal cells suppress immune responses to attenuate high-risk corneal transplantation rejection.过表达TLR3的脐带间充质基质细胞抑制免疫反应以减轻高危角膜移植排斥反应。
Stem Cell Res Ther. 2025 Jul 15;16(1):370. doi: 10.1186/s13287-025-04510-3.
2
Characterization and Evaluation of Rapamycin-Loaded Nano-Micelle Ophthalmic Solution.载雷帕霉素纳米胶束眼用溶液的表征与评价
J Funct Biomater. 2023 Jan 16;14(1):49. doi: 10.3390/jfb14010049.
3
Piperlongumine alleviates corneal allograft rejection suppressing angiogenesis and inflammation.
千里光碱通过抑制血管生成和炎症缓解角膜移植排斥反应。
Front Immunol. 2022 Dec 16;13:1090877. doi: 10.3389/fimmu.2022.1090877. eCollection 2022.
4
The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2.嘌呤能信号在抗包括 SARS-CoV-2 在内的病毒方面的潜力。
Front Immunol. 2022 Jun 17;13:904419. doi: 10.3389/fimmu.2022.904419. eCollection 2022.
5
P2X7 Receptor Expression and Signaling on Dendritic Cells and CD4 T Cells is Not Required but Can Enhance Th17 Differentiation.树突状细胞和CD4 T细胞上P2X7受体的表达及信号传导并非必需,但可增强Th17细胞分化。
Front Cell Dev Biol. 2022 Mar 8;10:687659. doi: 10.3389/fcell.2022.687659. eCollection 2022.